Sonidegib (Odomzo Capsules) Approved by FDA
Sonidegib (Odomzo Capsules) Approved by FDA
(Novartis Pharmaceuticals Corporation)
FDA approved sonidegib (Odomzo Capsules, Novartis Pharmaceuticals Corporation) for the treatment of patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. July 24, 2015.
More Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm455865.htm
